O'Toole C M, Tiptaft R C, Stevens A
Int J Cancer. 1982 Apr 15;29(4):391-5. doi: 10.1002/ijc.2910290405.
Antibody-dependent cell-mediated cytotoxicity (ADCC) was used to detect HLA-A, -B and -C antigens on in vitro-cultured urothelial cells of normal or malignant derivation. Alloantisera induced specific lysis of 51Cr-labelled targets by effector lymphoid cells from non-immune donors. HLA antisera were routinely titred to dilutions greater than or equal to 10(-3) on urothelial cells in primary or long-term culture. The HLA phenotype was compared for lymphoid cells and urothelial cells from eight individuals. HLA antigens detected by complement mediated lymphocytotoxicity were also detected on urothelial cells. No deletions or gains in HLA antigens were found on normal or malignant urothelial cultures as compared with donor lymphocyte HLA typings. The results show that the established urothelial cells lines J82, TCCSuP and SCaBER have retained their donor HLA phenotype. The established cell lines T24 and RT4 derived from transitional cell carcinomas and HCV-29 from urothelium were found to have distinctive HLA profiles although donor lymphocytes were not available for comparison. The serological crossreactions seen in complement mediated lymphocytotoxicity were clearly observed in ADCC. In particular, HLA-Cw5 was found to crossreact with HLA-Cw8. HLA-Cw5 was detected on 6/8 cultures of transitional cell carcinomas and this was confirmed by absorption analysis.
抗体依赖性细胞介导的细胞毒性作用(ADCC)被用于检测正常或恶性来源的体外培养尿路上皮细胞上的HLA - A、- B和 - C抗原。同种异体抗血清可诱导来自非免疫供体的效应淋巴细胞对51Cr标记的靶细胞进行特异性裂解。在原代或长期培养的尿路上皮细胞上,HLA抗血清通常被滴定至大于或等于10(-3)的稀释度。比较了8名个体的淋巴细胞和尿路上皮细胞的HLA表型。补体介导的淋巴细胞毒性检测到的HLA抗原也在尿路上皮细胞上被检测到。与供体淋巴细胞HLA分型相比,在正常或恶性尿路上皮培养物中未发现HLA抗原的缺失或增加。结果表明,已建立的尿路上皮细胞系J82、TCCSuP和SCaBER保留了其供体HLA表型。尽管没有供体淋巴细胞可供比较,但发现源自移行细胞癌的已建立细胞系T24和RT4以及源自尿路上皮的HCV - 29具有独特的HLA谱。在补体介导的淋巴细胞毒性中观察到的血清学交叉反应在ADCC中也清晰可见。特别是,发现HLA - Cw5与HLA - Cw8发生交叉反应。在6/8的移行细胞癌培养物中检测到HLA - Cw5,这通过吸收分析得到了证实。